TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model

被引:0
|
作者
Hiroyuki Inoue
Mutsunori Iga
Meng Xin
Saori Asahi
Takafumi Nakamura
Ryo Kurita
Masaharu Nakayama
Yukoh Nakazaki
Koichi Takayama
Yoichi Nakanishi
Kenzaburo Tani
机构
[1] Kyushu University,Division of Molecular and Clinical Genetics, Medical Institute of Bioregulation
[2] Kyushu University,Department of Advanced Cell and Molecular Therapy, Kyushu University Hospital
[3] Kyushu University,Institute of Diseases of the Chest
来源
关键词
Gene therapy; Antitumor immunity; GM-CSF; TARC; RANTES;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1399 / 1411
页数:12
相关论文
共 50 条
  • [41] Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer
    He, Qiushan
    Li, Jinlong
    Yin, Weihua
    Song, Zhichun
    Zhang, Zhen
    Yi, Tienan
    Tang, Jia
    Wu, Demin
    Lu, Yue
    Wang, Zhen
    Liu, Dan
    Zhang, Xiaoren
    Hu, Zhiming
    Gao, Jimin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (05) : 715 - 730
  • [42] The efficacy of a novel vaccine approach using tumor cells that ectopically express a codon-optimized murine GM-CSF in a murine tumor model
    Lin, Chu-Chi
    Tsai, Ching-Chou
    Lee, Jan-Mou
    Fang, Chih-Hao
    Chang, Kuo-Shian
    Wong, Kwong-Kwok
    Lin, Cheng-Tao
    Qiu, Jiantai Timothy
    VACCINE, 2016, 34 (01) : 134 - 141
  • [43] Protective antitumor immunity induced by fixed tumor cells in combination with adjuvant in a murine hepatoma model
    Huang, L
    Ohno, T
    CANCER LETTERS, 2003, 202 (02) : 153 - 159
  • [44] Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment
    Yan, Wan-Lun
    Wu, Chiao-Chieh
    Shen, Kuan-Yin
    Liu, Shih-Jen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [45] Ionic Liquid-Based Transcutaneous Peptide Antitumor Vaccine: Therapeutic Effect in a Mouse Tumor Model
    Shimizu, Taro
    Matsuzaki, Takaaki
    Fukuda, Shoichiro
    Yoshioka, Chihiro
    Shimazaki, Yuna
    Takese, Shunsuke
    Yamanaka, Katsuhiro
    Nakae, Takashi
    Ishibashi, Masaki
    Hamamoto, Hidetoshi
    Ando, Hidenori
    Ishima, Yu
    Ishida, Tatsuhiro
    AAPS JOURNAL, 2023, 25 (02):
  • [46] Ionic Liquid-Based Transcutaneous Peptide Antitumor Vaccine: Therapeutic Effect in a Mouse Tumor Model
    Taro Shimizu
    Takaaki Matsuzaki
    Shoichiro Fukuda
    Chihiro Yoshioka
    Yuna Shimazaki
    Shunsuke Takese
    Katsuhiro Yamanaka
    Takashi Nakae
    Masaki Ishibashi
    Hidetoshi Hamamoto
    Hidenori Ando
    Yu Ishima
    Tatsuhiro Ishida
    The AAPS Journal, 25
  • [47] Primary human immunity in a Trimera mouse model elicited by recombinant SFV-based tumor vaccine
    Ni, B
    Gao, WD
    Zhu, B
    Lin, ZH
    Wu, YZ
    IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION, 2004, : 361 - 368
  • [48] Mechanisms of cancer vaccine induced tumor immunity in an experimental murine pulmonary metastasis preclinical model
    Alalawi, Raed
    Lowe, Devin B.
    Aldrich, Joel F.
    Shearer, Michael H.
    Jumper, Cynthia A.
    Kennedy, Ronald C.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S602 - S602
  • [49] Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity
    Wang, LH
    Qi, XS
    Sun, YG
    Liang, L
    Ju, DW
    CANCER GENE THERAPY, 2002, 9 (10) : 819 - 824
  • [50] Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity
    Linhui Wang
    Xiaosheng Qi
    Yinghao Sun
    Li Liang
    Dianwen Ju
    Cancer Gene Therapy, 2002, 9 : 819 - 824